The smartphone-sized, battery-powered test is a cost-effective tool that can improve TB diagnoses, particularly in rural areas where facilities and equipment are less accessible. Dr. Tony Hu, a Tulane ...

Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ...

The investigators undertook a retrospective analysis of patients with advanced urothelial carcinoma who were longitudinally tested for ctDNA (MTM/mL) with a tumor-informed assay while on treatment ...

Russell Bradley as President and General Manager of Plus Therapeutics' wholly owned subsidiary, CNSide Diagnostics, LLC ...

Scientists at the Liverpool School of Tropical Medicine (LSTM) have developed a more precise diagnostic tool to distinguish ...